bluebird bio
BLUE
#9803
Rank
โ‚ฌ41.8 M
Marketcap
4,27ย โ‚ฌ
Share price
0.00%
Change (1 day)
-77.85%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: โ‚ฌ41.8 Million

As of December 2025 bluebird bio has a market cap of โ‚ฌ41.8 Million. This makes bluebird bio the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ41.8 M-46.38%
2024โ‚ฌ77.96 M-67.6%
2023โ‚ฌ0.24 B-55.02%
2022โ‚ฌ0.53 B-13.51%
2021โ‚ฌ0.61 B-73.51%
2020โ‚ฌ2.33 B-46.16%
2019โ‚ฌ4.33 B-8.63%
2018โ‚ฌ4.74 B-34.84%
2017โ‚ฌ7.28 B232.89%
2016โ‚ฌ2.18 B0.98%
2015โ‚ฌ2.16 B-11.15%
2014โ‚ฌ2.43 B570.6%
2013โ‚ฌ0.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚ฌ8.81 B 20,979.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ9.38 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ103.84 B 248,312.96%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
โ‚ฌ0.14 B 242.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ213.93 B 511,686.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
โ‚ฌ8.7 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA